What We’re Learning About Drug Company Payments to Doctors

Loeb & Loeb partner Scott Liebman is quoted on the impact of the federal government’s disclosure of payments made to doctors by pharmaceutical and medical device companies – information, which is being made public under a provision of the 2010 Affordable Care Act.
 
Click here to read the article on the New York Times’ website.